People · Operator
Named in public records as an officer, director or promoter · active 2022–2023 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CHARM Therapeutics Inc. | — | Pharma | Series B | $87.0M | $77.3M | 2022 |
Nihal Singh Sinha at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nihal Singh Sinha on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rishi Gupta | 1 | 12 |
| Briggs Morrison | 1 | 8 |
| Gary Glick | 1 | 7 |
| Kim Blackwell | 1 | 3 |
| Nihal Sinha | 1 | 2 |
| Mahesh Kudari | 1 | 1 |
| Matthew McAviney | 1 | 1 |
| Gary Singh Glick | 1 | 1 |
| Lakshyaditya Singh Aithani | 1 | 1 |
| Muzammil Singh Mansuri | 1 | 1 |
| Rishi Singh Gupta | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.